Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Doxorubicin-loaded cell-derived nanovesicles: an alternative targeted approach for anti-tumor therapy
Wei Jiang Goh, Choon Keong Lee, Shui Zou, et al.
International Journal of Nanomedicine (2017) Vol. Volume 12, pp. 2759-2767
Open Access | Times Cited: 101

Showing 26-50 of 101 citing articles:

Extracellular Vesicles in Therapeutics: A Comprehensive Review on Applications, Challenges, and Clinical Progress
Jiyoung Goo, Yeji Lee, Jeongmin Lee, et al.
Pharmaceutics (2024) Vol. 16, Iss. 3, pp. 311-311
Open Access | Times Cited: 11
Recent Advances in the Application of Engineered Exosomes from Mesenchymal Stem Cells for Regenerative Medicine
Reza Abbasi, Ghazal Alamdari-Mahd, Hadi Maleki, et al.
European Journal of Pharmacology (2025), pp. 177236-177236
Closed Access | Times Cited: 1
A glance over doxorubicin based-nanotherapeutics: From proof-of-concept studies to solutions in the market
Mara Gonçalves, Serge Mignani, João Rodrigues, et al.
Journal of Controlled Release (2019) Vol. 317, pp. 347-374
Closed Access | Times Cited: 66
Extracellular Vesicles in the Development of Cancer Therapeutics
Haoyao Sun, Stephanie Burrola, Jinchang Wu, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 6097-6097
Open Access | Times Cited: 53
Nanomedicine at the crossroads – A quick guide for IVIVC
Marc-Phillip Mast, Harshvardhan Modh, Carole Champanhac, et al.
Advanced Drug Delivery Reviews (2021) Vol. 179, pp. 113829-113829
Closed Access | Times Cited: 47
Mesenchymal stem cells, exosomes and exosome-mimics as smart drug carriers for targeted cancer therapy
Hongmei Liu, Shichen Deng, Lu Han, et al.
Colloids and Surfaces B Biointerfaces (2021) Vol. 209, pp. 112163-112163
Closed Access | Times Cited: 47
Exosome mimetics derived from bone marrow mesenchymal stem cells deliver doxorubicin to osteosarcoma in vitro and in vivo
Jinkui Wang, Mujie Li, Liming Jin, et al.
Drug Delivery (2022) Vol. 29, Iss. 1, pp. 3291-3303
Open Access | Times Cited: 36
Extracellular vesicle-mediated drug delivery in breast cancer theranostics
Toufik Abdul‐Rahman, Poulami Roy, Ranferi Eduardo Herrera‐Calderón, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
EXOPLEXs: Chimeric Drug Delivery Platform from the Fusion of Cell-Derived Nanovesicles and Liposomes
Wei Jiang Goh, Shui Zou, Choon Keong Lee, et al.
Biomacromolecules (2017) Vol. 19, Iss. 1, pp. 22-30
Closed Access | Times Cited: 53
Immune (Cell) Derived Exosome Mimetics (IDEM) as a Treatment for Ovarian Cancer
Simone Pisano, Irene Pierini, Jianhua Gu, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 49
New approaches in extracellular vesicle engineering for improving the efficacy of anti-cancer therapies
Migara Kavishka Jayasinghe, Melissa Tan, Boya Peng, et al.
Seminars in Cancer Biology (2021) Vol. 74, pp. 62-78
Closed Access | Times Cited: 41
Extracellular vesicles in endothelial cells: from mediators of cell-to-cell communication to cargo delivery tools
Enrico Desideri, Fabio Ciccarone, Maria Rosa Ciriolo, et al.
Free Radical Biology and Medicine (2021) Vol. 172, pp. 508-520
Closed Access | Times Cited: 37
Extracellular Vesicle (EV) biohybrid systems for cancer therapy: Recent advances and future perspectives
Yi-Hsuan Ou, Jeremy Liang, Bertrand Czarny, et al.
Seminars in Cancer Biology (2021) Vol. 74, pp. 45-61
Open Access | Times Cited: 36
Role of Exosomes for Delivery of Chemotherapeutic Drugs
Aragaw Gebeyehu, Nagavendra Kommineni, David G. Meckes, et al.
Critical Reviews in Therapeutic Drug Carrier Systems (2021) Vol. 38, Iss. 5, pp. 53-97
Open Access | Times Cited: 36
Extracellular Vesicles and Their Current Role in Cancer Immunotherapy
Carla Giacobino, Marta Canta, Cristina Fornaguera, et al.
Cancers (2021) Vol. 13, Iss. 9, pp. 2280-2280
Open Access | Times Cited: 35
Use of artificial cells as drug carriers
Sibel Emi̇r Di̇ltemi̇z, Maryam Tavafoghi, Natan Roberto de Barros, et al.
Materials Chemistry Frontiers (2021) Vol. 5, Iss. 18, pp. 6672-6692
Open Access | Times Cited: 34
Exosomes as Natural Nanocarriers for RNA-Based Therapy and Prophylaxis
Andrey Gorshkov, Lada Purvinsh, Alexandra Brodskaia, et al.
Nanomaterials (2022) Vol. 12, Iss. 3, pp. 524-524
Open Access | Times Cited: 28
Nanotechnological engineering of extracellular vesicles for the development of actively targeted hybrid nanodevices
Bianca Dumontel, Francesca Susa, Tania Limongi, et al.
Cell & Bioscience (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 27
Cell-derived artificial nanovesicle as a drug delivery system for malignant melanoma treatment
Ying-Yi Lin, Chung‐Yi Chen, Dik‐Lung Ma, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 147, pp. 112586-112586
Open Access | Times Cited: 25
Exosomes: Insights and therapeutic applications in cancer
Anita Raj Panigrahi, Srinivas Lankalapalli, Jagadeesh Panda
Translational Oncology (2022) Vol. 21, pp. 101439-101439
Open Access | Times Cited: 25
Nanoparticle Strategies to Improve the Delivery of Anticancer Drugs across the Blood–Brain Barrier to Treat Brain Tumors
Wouter J. F. Vanbilloen, Julian S. Rechberger, Jacob B. Anderson, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1804-1804
Open Access | Times Cited: 15
Bioengineered Mesenchymal-Stromal-Cell-Derived Extracellular Vesicles as an Improved Drug Delivery System: Methods and Applications
Cristiana Ulpiano, Cláudia L. da Silva, Gabriel A. Monteiro
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1231-1231
Open Access | Times Cited: 14
T Cell and Natural Killer Cell Membrane-Camouflaged Nanoparticles for Cancer and Viral Therapies
Fatma Ozsoy, Mahir M. Sharif, Nasrullah Jan, et al.
ACS Applied Bio Materials (2024) Vol. 7, Iss. 5, pp. 2637-2659
Open Access | Times Cited: 5
Biomimetic Nanoparticles for Basic Drug Delivery
Andrey Tikhonov, Artyom Kachanov, Alexandra Yudaeva, et al.
Pharmaceutics (2024) Vol. 16, Iss. 10, pp. 1306-1306
Open Access | Times Cited: 5
Genetically-engineered anti-PSMA exosome mimetics targeting advanced prostate cancer in vitro and in vivo
Maja Severic, Guanglong Ma, Sara Pereira, et al.
Journal of Controlled Release (2020) Vol. 330, pp. 101-110
Open Access | Times Cited: 39

Scroll to top